- United States
- /
- Electronic Equipment and Components
- /
- NasdaqGS:NOVT
Novanta Third Quarter 2024 Earnings: EPS Misses Expectations
Novanta (NASDAQ:NOVT) Third Quarter 2024 Results
Key Financial Results
- Revenue: US$244.4m (up 10% from 3Q 2023).
- Net income: US$19.2m (down 9.6% from 3Q 2023).
- Profit margin: 7.9% (down from 9.6% in 3Q 2023). The decrease in margin was driven by higher expenses.
- EPS: US$0.53 (down from US$0.59 in 3Q 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Novanta EPS Misses Expectations
Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 3.6%.
Looking ahead, revenue is forecast to grow 8.6% p.a. on average during the next 3 years, compared to a 7.3% growth forecast for the Electronic industry in the US.
Performance of the American Electronic industry.
The company's shares are up 6.6% from a week ago.
Risk Analysis
Before we wrap up, we've discovered 1 warning sign for Novanta that you should be aware of.
Valuation is complex, but we're here to simplify it.
Discover if Novanta might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NasdaqGS:NOVT
Novanta
Provides precision medicine and manufacturing, medical solutions, and robotics and automation solutions in the United States and internationally.
Moderate growth potential with mediocre balance sheet.